Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Navigation icon on Pluang platform
US Stocks
Invest in the world’s largest market with US Stocks
Navigation icon on Pluang platform
Crypto
Unleash the unlimited potential of Crypto
Navigation icon on Pluang platform
ID Stocks
Invest in leading Indonesian companies with ID Stocks
Navigation icon on Pluang platform
Mutual Funds
Worry-free investments with Mutual Funds
Navigation icon on Pluang platform
Gold
The simplest way to invest in Gold
Navigation icon on Pluang platform
Options
Maximize market opportunities with Options Trading
Navigation icon on Pluang platform
Crypto Futures
Leverage your potential with Crypto Futures
Navigation icon on Pluang platform
Explore
Choose from 1000+ available assets
Features
Pluang support - get 24/7 expert trading help
Pro Tools for Pro Traders
Uncover the powerful trading features
Pro Features
Navigation icon on Pluang platform
Pluang Web Trading
Navigation icon on Pluang platform
Leverage
Navigation icon on Pluang platform
Pluang support - get 24/7 expert trading help
Built for Investors
Experience investing with simplified features
Pockets
Navigation icon on Pluang platform
Auto Invest
Navigation icon on Pluang platform
USD Yield
Navigation icon on Pluang platform
Pluang Cuan
Navigation icon on Pluang platform
24-Hour Market
Navigation icon on Pluang platform
Aura AI
Navigation icon on Pluang platform
FeesSafety
Academy
Navigation icon on Pluang platform
Latest for You
Get up-to-date financial news and investing tips & information
Navigation icon on Pluang platform
Blog
Find various tips & information to become a knowledgeable investor
Navigation icon on Pluang platform
News and Analysis
Read the latest information about finance and investment
Navigation icon on Pluang platform
Learn
Become a smarter investor by learning the basics of investing
Navigation icon on Pluang platform
Glossary
Learn investment terms to understand investing better
More
Navigation icon on Pluang platform
Promo & Referral
Discover exclusive opportunities to level up your investments
Navigation icon on Pluang platform
Impact Report
Discover how your steps with Pluang contribute to big changes and lasting impact
Navigation icon on Pluang platform
Investment Clubs (Coming Soon)
Join hands with like-minded investors to grow wealth together
Pluang support - get 24/7 expert trading help
Support
About Us
Browse Pluang investment products menu
Help Center
Browse Pluang investment products menu
Contact
Browse Pluang investment products menu
FAQ
Browse Pluang investment products menu
Career
Browse Pluang investment products menu
Tax Reporting Guide
Browse Pluang investment products menu
Pluang+
|
Home/News Feed/VanEck Rare Earth ETF (REMX) targets rare earth supply risks amid US-China tensions and rising demand.
REMX
$98.49
+$1.67 +1.72%

VanEck Rare Earth ETF (REMX) targets rare earth supply risks amid US-China tensions and rising demand.

Market News
05 May 2026
Seeking Alpha
View Source
Neutral
pluang ai news

The VanEck Rare Earth and Strategic Metals ETF (REMX) provides focused exposure to the geopolitical and supply chain tensions between the U.S. and China over rare earth metals. It is recommended as a 5% satellite holding in aggressive portfolios due to its high concentration and risks linked to China. Major U.S. projects like Project Vault and FORGE aim to strengthen Western rare earth supply chains, but challenges remain from processing bottlenecks and Chinese dominance. Demand for rare earths is expected to grow driven by AI, defense, and clean energy sectors, with REMX's performance dependent on commodity cycles and geopolitical developments.

More News (REMX)

New drug REM-422 shows 43% response rate in rare cancer trial with durable effects and good safety.

New drug REM-422 shows 43% response rate in rare cancer trial with durable effects and good safety.

Remix Therapeutics announced positive Phase 1/2 trial results for REM-422, a novel oral MYB mRNA degrader, in patients with recurrent or metastatic adenoid cystic carcinoma (ACC). The trial showed a 43% overall response rate at the recommended Phase ...

Company Fundamentals
Bullish
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App